APA (7th ed.) Citation

Zuberbier, T., Muraro, A., Nurmatov, U., Arasi, S., Stevanovic, K., Anagnostou, A., . . . Cianferoni, A. (2024). GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management. Clinical & Translational Allergy, 14(11), 1. https://doi.org/10.1002/clt2.70002

Chicago Style (17th ed.) Citation

Zuberbier, Torsten, et al. "GA2LEN ANACARE Consensus Statement: Potential of Omalizumab in Food Allergy Management." Clinical & Translational Allergy 14, no. 11 (2024): 1. https://doi.org/10.1002/clt2.70002.

MLA (9th ed.) Citation

Zuberbier, Torsten, et al. "GA2LEN ANACARE Consensus Statement: Potential of Omalizumab in Food Allergy Management." Clinical & Translational Allergy, vol. 14, no. 11, 2024, p. 1, https://doi.org/10.1002/clt2.70002.